Shandong Sanyuan Biological Technology Co., Ltd. (hereinafter referred to as "the Company") held its fifth board meeting on February 4, 2026, where it approved the proposal regarding the continued use of temporarily idle excess funds for cash management. The Company plans to use no more than 60 million RMB for this purpose. The funds will be managed by the Company’s third board meeting within 12 months, and the specific investment products will be disclosed in a timely manner.
301206SZSE
Progress Announcement on Continued Use of Temporarily Idle Excess Funds for Cash Management
✨ AI Summary
The company announced its decision to continue using temporarily idle excess funds for cash management. The total amount involved is not to exceed 60 million RMB. The funds will be allocated to specific financial products with defined start and end dates, aiming for a projected annual return rate of up to 2.0%. This strategy is expected to enhance the company's financial management and investment income.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.